Company Info
| Year Established: | 2017 |
Contacts
| Primary: | Richard Yu, Ph.D. Co-Founder & CEO |
| Other: | Toshi Takeuchi, Ph.D. CSO |
Company Description
Abalone Bio's combines engineered living cells and data-driven computation to identify antibodies that functionally modulate the GPCR target - including activators.
